Acurx Pharmaceuticals, Inc. — Form D

Acurx Pharmaceuticals, Inc. of STATEN ISLAND, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-20. The offering totals $12.0M. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
David LuciDirectorJersey City, NJ
ROBERT G SHAWAHExecutive OfficerSTATEN ISLAND, NY
JAMES H DONOHUEDirectorSTATEN ISLAND, NY
CARL H SAILERDirectorSTATEN ISLAND, NY
JOSEPH H SCODARIDirectorSTATEN ISLAND, NY
ROBERT J DELUCCIADirectorSTATEN ISLAND, NY
ROBERT J DELUCCIAExecutive OfficerSTATEN ISLAND, NY
THOMAS H HARRISONDirectorSTATEN ISLAND, NY
JACK H DEANDirectorSTATEN ISLAND, NY
DAVID P LUCIDirectorSTATEN ISLAND, NY
DAVID P LUCIExecutive OfficerSTATEN ISLAND, NY
Carl G SailerDirectorWhite Plains, NY
Anthony G JadhonDirectorWhite Plains, NY
Paul G BaehrDirectorWhite Plains, NY
Mark G RathjenDirectorWhite Plains, NY
Michael G DuffyDirectorWhite Plains, NY
John G TerranaDirectorWhite Plains, NY
Katie G JadhonDirectorWhite Plains, NY
Robert ShawahExecutive OfficerSuwanee, GA
Robert DeLucciaDirectorWhite Plains, NY
Thomas HarrisonRelated PersonStaten Island, NY
David P. LuciRelated PersonStaten Island, NY
Robert J. DeLucciaRelated PersonStaten Island, NY
Robert G. ShawahRelated PersonStaten Island, NY
Jack H. DeanRelated PersonStaten Island, NY

Other filings by this issuer (9)

FiledFormOfferingSold
2026-04-29D$4.6M$4.6M
2025-06-27D$4.0M$4.0M
2025-03-21D$3.4M$3.4M
2025-01-17D$2.4M$2.4M
2020-01-17D$6.0M$455K
2019-10-30D/A$7.8M$7.8M
2018-10-30D/A$7.0M$3.8M
2018-05-31D/A$7.0M$2.9M
2018-04-03D$7.0M$2.1M

More